1. Introduction {#sec1-jcm-09-02141}
===============

*Nocardia* are gram-positive, aerobic, filamentous bacteria that most often cause pulmonary infection in immunosuppressed hosts, while isolated abdominal or retroperitoneal nocardiosis is rare \[[@B1-jcm-09-02141]\]. In extrapulmonary nocardiosis, malignancy is often suspected due to the presence of abdominal or cerebral masses \[[@B2-jcm-09-02141],[@B3-jcm-09-02141],[@B4-jcm-09-02141],[@B5-jcm-09-02141],[@B6-jcm-09-02141]\], which can lead to misdiagnosis. Additionally, accurate diagnosis may be challenging due to slow growth of nocardia species in culture \[[@B7-jcm-09-02141],[@B8-jcm-09-02141]\].

Here, we report the second case, to our knowledge, of isolated abdominal nocardiosis due to *Nocardia paucivorans*. We also provide a comprehensive review of the literature, summarizing the information on 39 previously published cases of intra-abdominal and retroperitoneal nocardiosis and 12 cases of peritoneal dialysis-related nocardia peritonitis \[[@B2-jcm-09-02141],[@B5-jcm-09-02141],[@B6-jcm-09-02141],[@B8-jcm-09-02141],[@B9-jcm-09-02141],[@B10-jcm-09-02141],[@B11-jcm-09-02141],[@B12-jcm-09-02141],[@B13-jcm-09-02141],[@B14-jcm-09-02141],[@B15-jcm-09-02141],[@B16-jcm-09-02141],[@B17-jcm-09-02141],[@B18-jcm-09-02141],[@B19-jcm-09-02141],[@B20-jcm-09-02141],[@B21-jcm-09-02141],[@B22-jcm-09-02141],[@B23-jcm-09-02141],[@B24-jcm-09-02141],[@B25-jcm-09-02141],[@B26-jcm-09-02141],[@B27-jcm-09-02141],[@B28-jcm-09-02141],[@B29-jcm-09-02141],[@B30-jcm-09-02141],[@B31-jcm-09-02141],[@B32-jcm-09-02141],[@B33-jcm-09-02141],[@B34-jcm-09-02141],[@B35-jcm-09-02141],[@B36-jcm-09-02141],[@B37-jcm-09-02141],[@B38-jcm-09-02141],[@B39-jcm-09-02141],[@B40-jcm-09-02141],[@B41-jcm-09-02141],[@B42-jcm-09-02141],[@B43-jcm-09-02141],[@B44-jcm-09-02141],[@B45-jcm-09-02141],[@B46-jcm-09-02141],[@B47-jcm-09-02141],[@B48-jcm-09-02141],[@B49-jcm-09-02141],[@B50-jcm-09-02141],[@B51-jcm-09-02141],[@B52-jcm-09-02141],[@B53-jcm-09-02141]\]. Finally, we will review published cases of infection with *Nocardia paucivorans*, a rare nocardial species.

2. Illustrative Case Report {#sec2-jcm-09-02141}
===========================

An 81-year-old man with diffuse large B-cell lymphoma presented in January 2019 with abdominal pain and night sweats. In 2009, he initially presented with abdominal pain, weight loss, night sweats, and fever. Abdominal CT showed a mesenteric mass adjacent to the ileocecal area. Histopathological examination of a surgically obtained biopsy specimen showed the presence of CD20- and CD3-positive lymphoma cells, a perifocal lymphohistocytiary inflammatory infiltrate as well as necrotic lymphoma tissue. A bone marrow biopsy was free of lymphoma cells. Weekly rituximab was administered for 4 weeks, in combination with vincristin and bleomycin for the first 3 weeks. Rituximab plus cyclophosphamide, hydroxydaunorubicin, oncovin and prednisolone (R-CHOP) was administered for a total of 6 cycles until full remission was achieved in February 2010. After a successfully treated low-grade nodal relapse in 2017, the patient remained asymptomatic until February 2018 when persistent hypogammaglobulinemia was first noted and intravenous immune globulin was given at 4-week intervals. Since the last relapse in 2017, the patient had received no immunosuppressive therapy.

In January 2019, the patient presented with generalized weakness, night sweats, and intermittent abdominal pain for the past 3 weeks, as well as fever and diarrhea for 1 week. On physical examination, the abdomen was soft and without tenderness. CRP (197 mg/L) and the white blood cell count (18,100/mm^3^) were elevated. A chest X-ray showed no signs of pulmonary infection, and on CT scan of the head there were no signs of cerebral nocardiosis. Abdominal CT showed a heterogeneous mass in the right adrenal region ([Figure 1](#jcm-09-02141-f001){ref-type="fig"}), with FDG-PET-CT showing locally increased FDG uptake and central necrosis. A biopsy specimen, radiologically obtained with CT-guidance revealed numerous granulocytes and histiocytes but no signs of malignancy, suggesting a retroperitoneal abscess.

A pigtail catheter was placed under CT-guidance for drainage of the abscess ([Figure 1](#jcm-09-02141-f001){ref-type="fig"}) and empiric antibiotic therapy with intravenous amoxicillin/clavulanic acid was initiated. Gram stain of the drainage fluid showed filamentous bacteria, consistent with *Nocardia species* ([Figure 2](#jcm-09-02141-f002){ref-type="fig"}). Culture grew *Nocardia paucivorans*, susceptible in vitro to ceftriaxone, imipenem, amikacin, trimethoprim-sulfamethoxazole (TMP-SMX), ciprofloxacin and minocycline and resistant to amoxicillin/clavulanic acid. *Nocardia paucivorans* was identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). The mass spectra were acquired using the Microflex LT system and analyzed with the MALDI Biotyper Compass 4.1 software (Bruker Daltonics, Bremen, Germany). The identification was confirmed by partial 16S rRNA gene sequencing as described previously \[[@B54-jcm-09-02141]\]. Antimicrobial susceptibility testing was performed with Liofilchem^®^ MIC Test Strips (Liofilchem, Roseto degli Abruzzi, Italy) on Mueller Hinton agar +5% horse blood +20 mg/l ß-NAD (MHF; bioMérieux, Marcy-l'Étoile, France), and the minimal inhibitory concentrations (MICs) were interpreted according to CLSI guidelines \[[@B55-jcm-09-02141]\]. PCR and culture were negative for mycobacteria. The route of acquisition of *Nocardia paucivorans* in this patient could not be identified.

Antibiotic therapy was changed to intravenous trimethoprim-sulfamethoxazole and amikacin, and the patient clinically improved. The trough-level of amikacin was monitored and kept in the recommended range. However, the patient developed acute renal failure (eGFR decrease from 50 to 14 mL/min) and metabolic acidosis. This prompted the change of antimicrobial treatment to ceftriaxone and minocycline, and renal function recovered.

Due to considerable residual abscess despite external drainage, surgical abscess drainage was performed and the patient further improved. He was discharged on oral minocycline and ciprofloxacin. On follow-up, six weeks postoperatively, he reported minimal abdominal pain, tolerated antibiotic therapy well, and blood inflammatory markers were normal. Antibiotic therapy was continued for a total of 6 months. On most recent follow-up, 6 months after antibiotics were discontinued, the patient was well, and abdominal ultrasound was unremarkable.

3. Methods {#sec3-jcm-09-02141}
==========

We reviewed the existing literature on abdominal nocardiosis and infections due to *Nocardia paucivorans*. To identify patients in the published literature, several PubMed searches were performed. Search items included "nocardiosis", "nocardia", "paucivorans", "abdominal", "retroperitoneal", "CAPD", "peritonitis" and "infection". Additional cases were identified through bibliographic review of retrieved publications. Abdominal nocardiosis was defined as clinical or radiological signs compatible with nocardiosis plus isolation of *Nocardia species* in at least one abdominal or retroperitoneal specimen regardless of the infection's origin and extent of dissemination. *Nocardia* peritonitis was defined as clinical signs of peritonitis plus isolation of *Nocardia species* in ascites or peritoneal dialysate. *N. paucivorans* infection was defined as clinical or radiological signs compatible with nocardiosis plus isolation of *N. paucivorans* in an appropriate specimen, with clinical or radiological signs of infection. We limited our review to English and German language publications since 1966. The initial searches led to 93 publications being retrieved, of which 29 were excluded (26 articles published prior to 1966, 2 publications in Japanese, 1 publication in Spanish). Therefore, the present review includes 64 publications, including 49 cases of *N. paucivorans* infection, 39 cases of abdominal or retroperitoneal nocardiosis, 12 cases of nocardial peritonitis, plus our own patient with abdominal *N. paucivorans* infection.

4. Literature Review and Discussion {#sec4-jcm-09-02141}
===================================

In this review of the literature, we will first discuss the presumed route of acquisition of nocardiosis based on previous case reports and reviews. Second, we will discuss previously reported infections with *N. paucivorans*. Third, we will concentrate on the characteristics of abdominal nocardiosis and *Nocardia* peritonitis.

4.1. Route of Nocardia acquisition {#sec4dot1-jcm-09-02141}
----------------------------------

*Nocardia* are ubiquitously present in soil, water and decaying vegetation \[[@B56-jcm-09-02141]\]. Infection is believed to occur mostly through inhalation or percutaneously (i.e., via local trauma, skin cuts or scrapes); intestinal inoculation has at least been suggested to occur \[[@B7-jcm-09-02141]\]. In immunocompetent individuals (1/3 of cases), nocardiosis tends to remain localized to the site of inoculation \[[@B7-jcm-09-02141]\]. With immunosuppression, disseminated nocardiosis may occur, clinically most often presenting as brain abscesses \[[@B7-jcm-09-02141],[@B56-jcm-09-02141],[@B57-jcm-09-02141]\]. Presumably, respiratory acquisition of *Nocardia* in immunosuppressed patients is followed by hematologic dissemination, eventually allowing infection at distant sites \[[@B22-jcm-09-02141],[@B38-jcm-09-02141]\]. Additionally, direct peritoneal inoculation has been reported in 12 cases of *Nocardia* peritonitis in patients on peritoneal dialysis \[[@B8-jcm-09-02141],[@B43-jcm-09-02141],[@B44-jcm-09-02141],[@B45-jcm-09-02141],[@B46-jcm-09-02141],[@B47-jcm-09-02141],[@B48-jcm-09-02141],[@B49-jcm-09-02141],[@B50-jcm-09-02141],[@B51-jcm-09-02141],[@B52-jcm-09-02141],[@B53-jcm-09-02141]\].

4.2. Infection Due to Nocardia Paucivorans {#sec4dot2-jcm-09-02141}
------------------------------------------

N. paucivorans was first isolated in sputum in 2000 \[[@B58-jcm-09-02141]\]. To our knowledge, 49 cases of N. paucivorans infection have been published \[[@B2-jcm-09-02141],[@B3-jcm-09-02141],[@B4-jcm-09-02141],[@B56-jcm-09-02141],[@B58-jcm-09-02141],[@B59-jcm-09-02141],[@B60-jcm-09-02141],[@B61-jcm-09-02141],[@B62-jcm-09-02141],[@B63-jcm-09-02141],[@B64-jcm-09-02141],[@B65-jcm-09-02141],[@B66-jcm-09-02141],[@B67-jcm-09-02141],[@B68-jcm-09-02141]\], and we summarize these in [Table 1](#jcm-09-02141-t001){ref-type="table"}. The majority (33 cases) were reported by Gray et al. from Queensland, Australia, and were identified retrospectively via 16S ribosomal DNA sequencing of archived biopsy specimens \[[@B63-jcm-09-02141]\]. Unfortunately, the paper by Gray et al. lacks details regarding therapy and outcome of most patients, limiting the information to be gained from these cases. Additionally, none of the 49 previously reported cases included detailed information on the presumed route of acquisition of N. paucivorans infection \[[@B2-jcm-09-02141],[@B3-jcm-09-02141],[@B4-jcm-09-02141],[@B56-jcm-09-02141],[@B58-jcm-09-02141],[@B59-jcm-09-02141],[@B60-jcm-09-02141],[@B61-jcm-09-02141],[@B62-jcm-09-02141],[@B63-jcm-09-02141],[@B64-jcm-09-02141],[@B65-jcm-09-02141],[@B66-jcm-09-02141],[@B67-jcm-09-02141],[@B68-jcm-09-02141]\].

In 18 of 49 cases (37%), no information was provided regarding the patients' immune status. Of the remaining 31 cases, 11 patients (35%) were reported to be immunocompetent while 20 patients (65%) were overtly immunocompromised or had an underlying clinical condition. Thus, nocardiosis with N. paucivorans involves immunocompetent and immunocompromised patients, similar to infection with other Nocardia species \[[@B1-jcm-09-02141],[@B7-jcm-09-02141]\].

Microbiologically documented lung involvement was reported in 29 of 49 cases (59%) of human N. paucivorans infection, while 19 cases (39%) involved the central nervous system (mainly brain abscesses). Additional cases include skin and muscle abscesses, bacteremia and endocarditis \[[@B3-jcm-09-02141],[@B4-jcm-09-02141],[@B56-jcm-09-02141],[@B58-jcm-09-02141],[@B59-jcm-09-02141],[@B60-jcm-09-02141],[@B61-jcm-09-02141],[@B62-jcm-09-02141],[@B63-jcm-09-02141],[@B65-jcm-09-02141],[@B66-jcm-09-02141],[@B68-jcm-09-02141]\]. There is one case of abdominal/retroperitoneal N. paucivorans infection in the literature, a 63-year old lung transplant recipient with a renal abscess published by Roy in 2018 \[[@B2-jcm-09-02141]\]. Our patient reported in [Section 2](#sec2-jcm-09-02141){ref-type="sec"} thus represents the second published case of intra-abdominal/retroperitoneal infection with N. paucivorans. N. paucivorans is typically susceptible in vitro to most commonly employed anti-nocardial agents \[[@B56-jcm-09-02141]\] with TMP-SMX being used most frequently.

4.3. Abdominal/Retroperitoneal Infection Due to Nocardia Species {#sec4dot3-jcm-09-02141}
----------------------------------------------------------------

There are 39 cases of abdominal/retroperitoneal nocardiosis reported in the English and German language literature since 1966 \[[@B2-jcm-09-02141],[@B5-jcm-09-02141],[@B6-jcm-09-02141],[@B9-jcm-09-02141],[@B10-jcm-09-02141],[@B11-jcm-09-02141],[@B12-jcm-09-02141],[@B13-jcm-09-02141],[@B14-jcm-09-02141],[@B15-jcm-09-02141],[@B16-jcm-09-02141],[@B17-jcm-09-02141],[@B18-jcm-09-02141],[@B19-jcm-09-02141],[@B20-jcm-09-02141],[@B21-jcm-09-02141],[@B22-jcm-09-02141],[@B23-jcm-09-02141],[@B24-jcm-09-02141],[@B25-jcm-09-02141],[@B26-jcm-09-02141],[@B27-jcm-09-02141],[@B28-jcm-09-02141],[@B29-jcm-09-02141],[@B30-jcm-09-02141],[@B31-jcm-09-02141],[@B32-jcm-09-02141],[@B33-jcm-09-02141],[@B34-jcm-09-02141],[@B35-jcm-09-02141],[@B36-jcm-09-02141],[@B37-jcm-09-02141],[@B38-jcm-09-02141],[@B39-jcm-09-02141],[@B40-jcm-09-02141],[@B41-jcm-09-02141],[@B42-jcm-09-02141]\] ([Table 2](#jcm-09-02141-t002){ref-type="table"} and [Table 3](#jcm-09-02141-t003){ref-type="table"}). In 16 of 39 cases (41%), concurrent involvement of the lungs and/or brain was recorded ([Table 3](#jcm-09-02141-t003){ref-type="table"}). Isolated abdominal nocardiosis with no lung or brain involvement was reported in 23 previous cases (59%) ([Table 2](#jcm-09-02141-t002){ref-type="table"}).

*N. asteroides* and *N. farcinica* (10 cases each) represent the most commonly isolated species. The route of *Nocardia* acquisition leading to abdominal or retroperitoneal infection remains unclear in most case reports. Some authors of published abdominal nocardiosis cases have speculated on the route of acquisition, which may have included inhalation of infected dust followed by hematogenous spread of *Nocardia species* ([Table 2](#jcm-09-02141-t002){ref-type="table"}, case 23) \[[@B26-jcm-09-02141]\], and acquisition via infected pet dogs with skin lesions due to distemper virus ([Table 2](#jcm-09-02141-t002){ref-type="table"}, case 22) \[[@B25-jcm-09-02141]\]. While direct intestinal inoculation has been suggested to occur \[[@B7-jcm-09-02141]\], involvement of the intestines (jejenum, ileum or colon) was observed in only 6 cases (15%), suggesting that hematogenous spread from an extraabdominal inoculation site seems the more likely scenario in most cases.

Patients with impaired cell-mediated immunity such as solid organ transplant recipients and patients with advanced HIV infection may be at particular risk for contracting disseminated nocardiosis \[[@B7-jcm-09-02141],[@B57-jcm-09-02141]\]. Risk factors for abdominal nocardiosis remain a matter of speculation. One patient ([Table 2](#jcm-09-02141-t002){ref-type="table"}, case 14) had colon cancer with a resulting bowel perforation and abscess at this site \[[@B42-jcm-09-02141]\]. N. veterana was cultured from the abscess, and the authors speculated that local tissue injury in the setting of the malignancy may have allowed the organism to establish infection here. In a patient with AIDS and renal nocardiosis ([Table 2](#jcm-09-02141-t002){ref-type="table"}, case 13), the authors suggested that local kidney damage caused by urolithiasis with subsequent hydonephrosis might have predisposed the patient to localized nocardiosis of the kidney \[[@B18-jcm-09-02141]\].

As in our patient reported in [Section 2](#sec2-jcm-09-02141){ref-type="sec"}, isolation of Nocardia species in the renal or adrenal region was the most common infection site amongst previous cases of abdominal or retroperitoneal nocardiosis (15 cases, 38%). Further presentations include abscesses of the liver (7 cases, 18%), spleen (3 cases, 8%) and ovaries (2 cases, 5%). Two thirds of the patients (26 cases, 66%) had a least one immunocomprimising condition, in line with the literature on Nocardia species in general \[[@B1-jcm-09-02141],[@B7-jcm-09-02141]\]. The mortality rate was high (36%; 14 of 39 cases). Only 3 patients who died were reported to be immunocompetent. Unsuprisingly, mortality was higher in patients with disseminated nocardiosis than in those with isolated abdominal or retroperitoneal disease. Overall, abdominal/retroperitoneal nocardiosis seems to affect primarily adults, with only 4 cases (10%) being diagnosed under the age of 18 years.

Accurate diagnosis of abdominal nocardiosis may be challenging due to the non-specific clinical and radiological findings. Additionally, Nocardia are often not visualized on initial stains, delaying clinical diagnosis and effective therapy \[[@B2-jcm-09-02141]\]. Due to the slow growth of Nocardia species, adequate culture incubation of at least 5 days should be considered \[[@B2-jcm-09-02141],[@B8-jcm-09-02141]\]. Abdominal nocardiosis is often misdiagnosed as tuberculosis \[[@B25-jcm-09-02141],[@B34-jcm-09-02141]\] or abdominal malignancy such as adrenal \[[@B5-jcm-09-02141]\], ovarian \[[@B19-jcm-09-02141]\], thyroid \[[@B31-jcm-09-02141]\] or renal carcinoma \[[@B2-jcm-09-02141],[@B39-jcm-09-02141]\]. Misdiagnosis can lead to erroneous therapy including antituberculous treatment or even extensive surgery \[[@B19-jcm-09-02141],[@B25-jcm-09-02141]\]. Suspected to have ovarian carcinoma, one published patient ([Table 2](#jcm-09-02141-t002){ref-type="table"}, case 15) underwent total hysterectomy, salpingo-oophorectomy and local lymph node dissection before being diagnosed with abdominal nocardiosis \[[@B19-jcm-09-02141]\].

Successful therapy typically included either percutaneous or surgical abscess drainage plus prolonged antimicrobial therapy ranging from 3 to 12 months. As for other forms of nocardiosis, effective antibiotics for abdominal Nocardia infections include trimethoprim-sulfamethoxazole (TMP-SMX), third-generation cephalosporins, extended-spectrum quinolones, carbapenemes, minocycline and linezolid \[[@B2-jcm-09-02141]\]. In previous published cases of abdominal and retroperitoneal nocardiosis, TMP/SMX was the most commonly used antimicrobial agent ([Table 2](#jcm-09-02141-t002){ref-type="table"} and [Table 3](#jcm-09-02141-t003){ref-type="table"}). Given the typically prolonged antimicrobial therapy and the frequent use of combination therapy, kidney and liver function as well as potential pharmacological interactions should be closely monitored as demonstrated by our case report ([Section 2](#sec2-jcm-09-02141){ref-type="sec"}).

4.4. Peritoneal Dialysis-Related Nocardia Peritonitis {#sec4dot4-jcm-09-02141}
-----------------------------------------------------

*Nocardia species* is a rare cause of peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD), with 12 published cases in the literature, which we summarize in [Table 4](#jcm-09-02141-t004){ref-type="table"} \[[@B8-jcm-09-02141],[@B43-jcm-09-02141],[@B44-jcm-09-02141],[@B45-jcm-09-02141],[@B46-jcm-09-02141],[@B47-jcm-09-02141],[@B48-jcm-09-02141],[@B49-jcm-09-02141],[@B50-jcm-09-02141],[@B51-jcm-09-02141],[@B52-jcm-09-02141],[@B53-jcm-09-02141]\]. Peritonitis is an important complication leading to technique failure, hospitalization and even mortality in CAPD patients \[[@B53-jcm-09-02141]\]. Regular fluid exchange via the permanent percutaneous catheter exposes CAPD patients (but not patients on hemodialysis) to an increased risk for bacterial peritoneal contamination, which occasionally may include opportunistic pathogens such as *Nocardia*.

Identifying and treating Nocardia peritonitis may be difficult for several reasons. First, the clinical presentation of Nocardia peritonitis typically is no different from ordinary bacterial peritonitis \[[@B47-jcm-09-02141]\]. Second, Nocardia may tend to form clumps in liquid environments, dispersing non-uniformly in peritoneal fluid, which may explain why Nocardia peritonitis can be difficult to identify \[[@B45-jcm-09-02141]\]. Third, Nocardia grow slowly in culture, and the infection often presents as a "culture-negative" peritonitis, unresponsive to empirical antibiotic treatment. Extending the incubation time of the dialysate to a minimum of 10 days should be considered in cases of culture-negative and antibiotic-non-responsive peritonitis in CAPD-patients \[[@B8-jcm-09-02141]\]. The finding of slow growing gram-positive rods in dialysate culture should raise the suspicion of Nocardia peritonitis \[[@B49-jcm-09-02141]\]. Trimethoprim-sulfamethoxazole (TMP/SMX), often in combination with other antimicrobial agents, appears to be the treatment of choice \[[@B50-jcm-09-02141],[@B51-jcm-09-02141]\]. Intraperitoneal antibiotic treatment is the preferred route of administration. In 5 of the 12 published CAPD patients with Nocardia peritonitis, intraperitoneal antibiotic administration was successful without removal of the catheter and therefore without technique failure. In the remaining cases, due to initial treatment failure, the PD-catheter was removed, and the patient switched to maintenance hemodialysis, and antibiotic treatment was given orally or intravenously until full resolution of the infection \[[@B48-jcm-09-02141],[@B51-jcm-09-02141]\].

5. Conclusions {#sec5-jcm-09-02141}
==============

Human nocardiosis is a rare opportunistic disease affecting primarily immunosuppressed adults. However, one third of patients have no immunocompromising condition \[[@B1-jcm-09-02141],[@B7-jcm-09-02141],[@B63-jcm-09-02141]\]. The acquisition route of abdominal nocardiosis typically is unclear. Hematologic dissemination after pulmonary or percutaneous inoculation and direct abdominal inoculation have been suggested to occur \[[@B7-jcm-09-02141],[@B22-jcm-09-02141],[@B38-jcm-09-02141]\]. In addition, 12 cases of direct peritoneal inoculation in patients with continuous ambulatory peritoneal dialysis have been reported \[[@B8-jcm-09-02141],[@B43-jcm-09-02141],[@B44-jcm-09-02141],[@B45-jcm-09-02141],[@B46-jcm-09-02141],[@B47-jcm-09-02141],[@B48-jcm-09-02141],[@B49-jcm-09-02141],[@B50-jcm-09-02141],[@B51-jcm-09-02141],[@B52-jcm-09-02141],[@B53-jcm-09-02141]\]. In abdominal nocardiosis, malignancy is often suspected due to the presence of an abdominal mass \[[@B2-jcm-09-02141],[@B3-jcm-09-02141],[@B4-jcm-09-02141],[@B5-jcm-09-02141],[@B6-jcm-09-02141]\]. In our patient, an FDG-avid mass on FDG-PET led to suspicion of malignancy recurrence. Thus, biopsy of these masses and appropriate microbiological tests (including modified acid-fast staining, PCR, and culture) is crucial. Because of slow growth of *Nocardia species*, cultures should be incubated for at least 10 days to avoid false-negative results \[[@B8-jcm-09-02141]\]. *N. asteroides* and *N. farcinica* are the most commonly isolated species in abdominal nocardiosis. *N. paucivorans* is a rare species leading to abdominal nocardiosis with only one previous case report, our patient thus representing the second published case. As in our patient, isolation of *Nocardia* species in the renal or adrenal region was the most common infection site amongst previous cases of abdominal or retroperitoneal nocardiosis. To date, there are no therapy guidelines for abdominal nocardiosis. In reported cases, successful therapy usually included either percutaneous or surgical abscess drainage plus prolonged combination antimicrobial therapy including TMP/SMX ranging from 3 to 12 months, as recommended for other forms of nocardiosis \[[@B69-jcm-09-02141]\]. As demonstrated by our case report, liver and renal function as well as potential pharmacological interactions should be closely monitored during antimicrobial therapy.
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![**Upper row**: 11 × 6 cm retroperitoneal mass in the right adrenal loge (thin white arrows) with contact to diaphragm, liver and retroperitoneal vessels. The pararenal space is not involved. The mass shows an inhomogeneous enhancement. The right adrenal gland itself cannot be distinguished. **Lower row**: Mass after puncture and CT guided drainage with a pigtail catheter (thick white arrow).](jcm-09-02141-g001){#jcm-09-02141-f001}

![(**A**) Histologic examination of a retroperitoneal biopsy specimen demonstrates a diffuse neutrophilic infiltrate with necrosis and cellular debris. High magnification of a typical area of one of these abscesses with neutrophils, debris and liquefactive necrosis. Organisms are not visible on routine H&E stain. (**B**,**C**) Gram stain shows filamentous bacteria (arrows), consistent with Nocardia species. The organisms are Gram-variable or weakly Gram positive, thin and filamentous, and focally concentrated.](jcm-09-02141-g002){#jcm-09-02141-f002}

jcm-09-02141-t001_Table 1

###### 

Previously published cases of *Nocardia paucivorans* infection.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case n°/Reference            Year \*\*   Age   Sex   Site                            Immune Status                               Therapy Regimen                                            Therapy Duration   Outcome
  ---------------------------- ----------- ----- ----- ------------------------------- ------------------------------------------- ---------------------------------------------------------- ------------------ ----------
  1 \[[@B58-jcm-09-02141]\]    2000        51    M     Sputum                          Chronic lung disease                        NR                                                         NR                 NR

  2 \[[@B59-jcm-09-02141]\]    2002        40    F     Brain abscess                   NR                                          NR                                                         NR                 NR

  3 \[[@B60-jcm-09-02141]\]    2002        63    M     Brain abscess                   Low CD4+ count of unknown origin            Cef, Amp, Amk, Mer, Levo, Mino                             \>6 months         survived

  4 \[[@B61-jcm-09-02141]\]    2006        54    M     Sputum, BAL, lung biopsy        Immunocompetent                             TMP/SMX, A/clav, Cip                                       6 months           NR

  5 \[[@B62-jcm-09-02141]\]    2006        63    M     Brain abscess                   Immunocompetent                             Surgical resection, TMP/SMX                                3 months           survived

  6 \[[@B63-jcm-09-02141]\]    2007        52    M     Lung abscess                    NR                                          NR                                                         NR                 died

  7 \[[@B63-jcm-09-02141]\]    2007        55    M     Brain abscess                   NR                                          NR                                                         NR                 NR

  8 \[[@B63-jcm-09-02141]\]    2007        NR    M     Pleural fluid                   NR                                          NR                                                         NR                 NR

  9 \[[@B63-jcm-09-02141]\]    2007        44    M     Mediastinal lymph node          NR                                          NR                                                         NR                 NR

  10 \[[@B63-jcm-09-02141]\]   2007        78    F     Lung abscess                    Chronic lung disease                        NR                                                         NR                 NR

  11 \[[@B63-jcm-09-02141]\]   2007        50    F     Sputum                          NR                                          NR                                                         NR                 NR

  12 \[[@B63-jcm-09-02141]\]   2007        41    M     Brain abscess                   Hodgkin's lymphoma                          NR                                                         NR                 NR

  13 \[[@B63-jcm-09-02141]\]   2007        53    M     Lung abscess                    NR                                          NR                                                         NR                 NR

  14 \[[@B63-jcm-09-02141]\]   2007        58    F     Brain abscess                   Corticosteroid therapy                      NR                                                         NR                 NR

  15 \[[@B63-jcm-09-02141]\]   2007        66    F     Sputum                          NR                                          NR                                                         NR                 NR

  16 \[[@B63-jcm-09-02141]\]   2007        54    M     Endocarditis, brain abscess,    NR                                          NR                                                         NR                 NR

  skin abscess                                                                                                                                                                                                   

  17 \[[@B63-jcm-09-02141]\]   2007        65    F     Sputum                          NR                                          NR                                                         NR                 NR

  18 \[[@B63-jcm-09-02141]\]   2007        72    F     Lung abscess                    Corticosteroid therapy                      NR                                                         NR                 NR

  19 \[[@B63-jcm-09-02141]\]   2007        66    M     Brain abscess                   Immunosuppression \*                        NR                                                         NR                 NR

  20 \[[@B63-jcm-09-02141]\]   2007        74    M     BAL fluid                       NR                                          NR                                                         NR                 NR

  21 \[[@B63-jcm-09-02141]\]   2007        NR    M     Sputum                          NR                                          NR                                                         NR                 NR

  22 \[[@B63-jcm-09-02141]\]   2007        74    M     Skin abscess                    NR                                          NR                                                         NR                 NR

  23 \[[@B63-jcm-09-02141]\]   2007        57    M     Brain abscess, pneumonia        NR                                          NR                                                         NR                 NR

  24 \[[@B63-jcm-09-02141]\]   2007        80    M     Lung, skin                      NR                                          NR                                                         NR                 NR

  25 \[[@B63-jcm-09-02141]\]   2007        62    M     Skin                            Immunocompetent                             NR                                                         NR                 NR

  26 \[[@B63-jcm-09-02141]\]   2007        87    M     Sputum                          NR                                          NR                                                         NR                 NR

  27 \[[@B63-jcm-09-02141]\]   2007        77    F     BAL fluid                       Immunocompetent                             NR                                                         NR                 NR

  28 \[[@B63-jcm-09-02141]\]   2007        50    M     Sputum                          Lung cancer                                 NR                                                         NR                 NR

  29 \[[@B63-jcm-09-02141]\]   2007        67    M     Brain abscess                   Diabetes mellitus                           NR                                                         NR                 NR

  30 \[[@B63-jcm-09-02141]\]   2007        67    M     Sputum                          Immunocompetent                             NR                                                         NR                 NR

  31 \[[@B63-jcm-09-02141]\]   2007        47    F     Sputum                          NR                                          NR                                                         NR                 NR

  32 \[[@B63-jcm-09-02141]\]   2007        66    F     Sputum                          Previous lung infection                     NR                                                         NR                 NR

  33 \[[@B63-jcm-09-02141]\]   2007        46    M     Sputum                          Immunocompetent                             NR                                                         NR                 NR

  34 \[[@B63-jcm-09-02141]\]   2007        79    M     Pleural fluid                   Corticosteroid therapy                      NR                                                         NR                 NR

  35 \[[@B63-jcm-09-02141]\]   2007        76    M     Pleural fluid                   Immunocompetent                             NR                                                         NR                 NR

  36 \[[@B63-jcm-09-02141]\]   2007        61    M     Skin abscess                    NR                                          NR                                                         NR                 NR

  37 \[[@B63-jcm-09-02141]\]   2007        60    M     Blood                           Chemotherapy                                NR                                                         NR                 NR

  38 \[[@B63-jcm-09-02141]\]   2007        53    M     BAL fluid and skin lesion       Smoking and other drug abuse, Hepatitis C   Tica/clav, Rox, TMP/SMX                                    12 months          survived

  39 \[[@B56-jcm-09-02141]\]   2014        50    M     M. iliopsoas, brain, lung,      Smoking and other drug abuse                TMP/SMX, Imi, Mox                                          12 months          survived

  mediastinal lymph nodes                                                                                                                                                                                        

  40 \[[@B64-jcm-09-02141]\]   2015        70    M     Brain abscesses                 Multiple Myeloma under chemotherapy         TMP/SMX, Mer, Cip                                          12 months          survived

  41 \[[@B65-jcm-09-02141]\]   2016        50    M     Brain abscesses                 Smoking and other drug abuse                TMP/SMX, Imi, Line, Mox                                    12 months          survived

  42 \[[@B66-jcm-09-02141]\]   2016        80    F     Brain and lung abscess          Immunocompetent                             Surgical resection, TMP/SMX, Cef                           9 months           survived

  43 \[[@B66-jcm-09-02141]\]   2016        50    M     Spinal cord, lung               Alcohol abuse                               Surgical resection, TMP/SMX, Mer, Cef                      9 months           survived

  44 \[[@B66-jcm-09-02141]\]   2016        59    M     Brain and lung abscess          Immunocompetent                             TMP/SMX, Mer                                               12 months          survived

  45 \[[@B67-jcm-09-02141]\]   2016        54    M     Brain abscess                   Immunocompetent                             Cef, Met, Mer, Line, Imi, Van, Rif, TMP/SMX                21 weeks           survived

  46 \[[@B3-jcm-09-02141]\]    2018        61    M     Brain abscess                   Myasthenia gravis,\                         TMP/SMX, Cef, Met, Line, Levo                              11 months          survived
                                                                                       corticosteroid therapy                                                                                                    

  47 \[[@B2-jcm-09-02141]\]    2018        66    F     Renal abscess                   Post Lung Transplantation                   TMP/SMX, Imi                                               9--12 months       survived

  48 \[[@B68-jcm-09-02141]\]   2018        42    M     Lung empyema                    Suspected silicosis                         TMP/SMX                                                    NR                 survived

  49 \[[@B4-jcm-09-02141]\]    2019        52    F     Brain abscess                   Immunocompetent                             Surgical resection, Cef, TMP/SMX, Levo                     13 months          survived

  50 \[present report\]                    81    M     Abscess in right adrenal loge   B-Cell Lymphoma,\                           Surgical resection, A/clav, TMP/SMX, Amk, Cef, Mino, Cip   6 months           survived
                                                                                       Hypogammaglobulinemia                                                                                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations**: Amk = amikacin; Amp = ampicillin; A/clav = amoxicillin + clavulanic acid; BAL = bronchoalveolar lavage; Cef = ceftriaxone; Cip = ciprofloxacin; Imi = imipenem; Levo = levofloxacin; Line = linezolid; Mer = meropenem; Met = metronidazol; Mino = minocycline; Mox = moxifloxacin; NR = not reported; Rif = rifampicin; Rox = roxifloxacin; Tica/clav = ticarcillin + clavulanic acid; TMP/SMX = trimethoprim-sulfamethoxazole; Van = vancomycin; \* not further specified; \*\* Year of publication.

jcm-09-02141-t002_Table 2

###### 

Previously published cases of isolated abdominal/retroperitoneal nocardiosis.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case n°/Reference            Year \*\*   Age   Sex   Species             Site                                                          Immune Status                             Therapy Regimen                                            Therapy Duration   Outcome
  ---------------------------- ----------- ----- ----- ------------------- ------------------------------------------------------------- ----------------------------------------- ---------------------------------------------------------- ------------------ ----------
  1 \[[@B28-jcm-09-02141]\]    1976        49    F     NR                  Spleen abscess                                                Immunocompetent                           Sulfisoxazole                                              NR                 survived

  2 \[[@B9-jcm-09-02141]\]     1981        26    F     *N. asteroides*     Perirenal area \*                                             Post renal transplant                     Sulphatriad, fusidic acid                                  NR                 survived

  3 \[[@B10-jcm-09-02141]\]    1983        11    F     *N. asteroides*     Liver and kidney abscesses                                    Immunocompetent                           Surgical resection, Amk, TMP/SMX, Sulphadimidine           12 weeks           survived

  4 \[[@B11-jcm-09-02141]\]    1986        76    M     *N. asteroides*     Pancreas abscess                                              Immunocompetent                           Surgical resection, A/clav, Amk, Orn, TMP/SMX              NR                 survived

  5 \[[@B41-jcm-09-02141]\]    1990        19    M     *N. brasiliensis*   Cholecystitis and Peritonitis                                 AIDS                                      NR                                                         7 days             died

  6 \[[@B12-jcm-09-02141]\]    1991        38    M     *N. asteroides*     Left suprarenal abscess                                       AIDS                                      Surgical resection                                         NR                 died

  7 \[[@B13-jcm-09-02141]\]    1996        67    M     *N. asteroides*     Abdominal aortic aneurysm                                     Immunocompetent                           TMP/SMX, Amk                                               NR                 survived

  8 \[[@B14-jcm-09-02141]\]    2003        42    M     *N. farcinica*      Psoas abscess                                                 Immunocompetent                           TMP/SMX                                                    11 months          survived

  9 \[[@B15-jcm-09-02141]\]    2004        37    F     NR                  Abdominal abscess                                             M. Crohn                                  NR                                                         NR                 NR

  10 \[[@B5-jcm-09-02141]\]    2004        34    M     *N. asteroides*     Left Adrenal abscess                                          AIDS                                      Surgical resection, TMP/SMX, Cef                           NR                 survived

  11 \[[@B16-jcm-09-02141]\]   2007        25    F     NR                  Bilateral kidney abscesses                                    Corticosteroids and Azathioprin for SLE   Methylprednisolone                                         NR                 died

  12 \[[@B17-jcm-09-02141]\]   2007        44    F     NR                  Jejunum                                                       Post liver transplant                     Surgical resection, Imi, Van                               NR                 died

  13 \[[@B18-jcm-09-02141]\]   2009        55    M     NR                  Kidney abscess                                                AIDS                                      Surgical resection                                         NR                 NR

  14 \[[@B42-jcm-09-02141]\]   2010        83    F     *N. veterana*       Bowel abscess                                                 Colon cancer                              Surgical resection, Cef, Gen, Met, TMP/SMX                 NR                 survived

  15 \[[@B19-jcm-09-02141]\]   2011        32    F     NR                  Bilateral abscesses of ovaries and fallopian tubes, omentum   Immunocompetent                           Surgical resection, Mino, TMP/SMX, Amk, Line, Cip          6 Months           survived

  16 \[[@B20-jcm-09-02141]\]   2012        59    F     *N. farcinica*      Right adrenal compartment                                     Chronic hepatitis C,\                     Amk, Cefu, TMP/SMX                                         4 months           died
                                                                                                                                         post treatment for lymphoma                                                                                             

  17 \[[@B21-jcm-09-02141]\]   2012        54    F     NR                  Colon                                                         Immunocompetent                           Surgical resection, antibiotics not specified              NR                 survived

  18 \[[@B22-jcm-09-02141]\]   2013        30    F     NR                  Left adnexal collection \*                                    Immunocompetent                           TMP/SMX, Amk                                               6 months           survived

  19 \[[@B24-jcm-09-02141]\]   2016        58    F     *N. farcinica*      Colon, blood                                                  TNFa-antagonist for M. Crohn              Van, Met, Imi, Amk, TMP/SMX                                12 months          survived

  20 \[[@B23-jcm-09-02141]\]   2017        59    M     *N. farcinica*      Liver abscess                                                 Post liver transplant                     TMP/SMX, Amk, Imi                                          NR                 survived

  21 \[[@B2-jcm-09-02141]\]    2018        63    F     *N. paucivorans*    Renal abscess                                                 Post lung transplant                      Surgical resection, Imi, TMP/SMX                           9--12 months       NR

  22 \[[@B25-jcm-09-02141]\]   2019        63    M     *N. farcinica*      Liver (hepatitis)                                             Immunocompetent                           TMP/SMX, Amk                                               4 weeks            died

  23 \[[@B26-jcm-09-02141]\]   2019        11    F     *N. farcinica*      Abdominal abscesses                                           Post renal transplant                     TMP/SMX, Mer, Imi, Cila, Line                              NR                 NR

  24 \[present report\]                    81    M     *N. paucivorans*    Right adrenal space                                           B-Cell Lymphoma, Hypogammaglobulinemia    Surgical resection, A/clav, TMP/SMX, Amk, Cef, Mino, Cip   6 months           survived
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations**: AIDS = acquired immunodeficiency syndrome; Amk = amikacin; A/clav = amoxicillin + clavulanic acid; Cef = ceftriaxone; Cefu = cefuroxime; Cila = cilastin; Cip = ciprofloxacin; Gen = gentamycin; Imi = imipenem; Line = linezolid; Mer = meropenem; Mino = minocycline; NR = not reported; Orn = ornidazole; SLE = systemic lupus erythematodes; TNFa = tumor necrosis factor alpha; TMP/SMX = trimethoprim-sulfamethoxazole; Van = vancomycin; \* not further specified; \*\* Year of publication.

jcm-09-02141-t003_Table 3

###### 

Previously published cases of disseminated nocardiosis with abdominal/retroperitoneal infection.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case n°/Reference            Year \*\*   Age   Sex   Species                   Site                                                        Immune Status                                              Therapy Regimen                                    Therapy Duration   Outcome
  ---------------------------- ----------- ----- ----- ------------------------- ----------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------- ------------------ ----------
  1 \[[@B27-jcm-09-02141]\]    1975        13    M     *N. asteroides*           Lungs, liver, pancreas, lymph nodes                         Immunocompetent                                            Surgical resection, sulphadiazine, sulfisoxazole   6 months           NR

  2 \[[@B29-jcm-09-02141]\]    1997        59    M     *N. otitidiscaviarum*     Thoracoabdominal abscess, lung                              HIV positive                                               Surgical drainage, TMP/SMX, Amk, Cefotaxime        NR                 survived

  3 \[[@B30-jcm-09-02141]\]    1998        49    F     *N. asteroides*           Left adrenal abscess, spleen, lung                          chronic steroids for RA                                    Surgical resection                                 NR                 survived

  4 \[[@B34-jcm-09-02141]\]    2004        32    M     *N. brasiliensis*         Lung, intestines                                            AIDS                                                       Surgical resection                                 NR                 died

  5 \[[@B17-jcm-09-02141]\]    2007        30    M     *N. asteroides*           Lung, pleura, abdomen \*                                    Post kidney transplant, chemotherapy, corticosteroids      NR                                                 NR                 survived

  6 \[[@B31-jcm-09-02141]\]    2007        67    M     *N. asteroides*           Pancreas, omentum, brain, lungs, thyroid                    Chronic steroids for Still's disease                       Mer, Amk, TMP/SMX                                  NR                 died

  7 \[[@B32-jcm-09-02141]\]    2009        69    M     *N. farcinica*            Adrenal glands, brain, lung, skin, muscle                   Post liver transplant                                      TMP/SMX                                            7 months           survived

  8 \[[@B6-jcm-09-02141]\]     2010        66    F     *N. farcinica*            Brain, bilateral adrenal abscesses, abdominal lymph nodes   aTNF-therapy for Psoriasis                                 Van, Amp, Mer, Voriconazole, TMP/SMX, Line         2.5 months         died

  9 \[[@B33-jcm-09-02141]\]    2010        61    F     *N. nova*                 Lung, skin, kidney, pancreas, brain                         Chronic steroids and Azathioprine for ulcerative colitis   TMP/SMX                                            1 year             survived

  10 \[[@B35-jcm-09-02141]\]   2011        42    M     *N. concava*              Lung, liver                                                 Chronic steroids for polychondritis                        Sulphadiazine, Van, Imi, Cip, Amk                  25 days            died

  11 \[[@B20-jcm-09-02141]\]   2012        68    F     *N. farcinica*            Right kidney abscess, brain abscess, lung                   Anorexia nervosa                                           Cef, Erythromycin, TMP/SMX, Amk, Imi, Cip          65 days            died

  12 \[[@B36-jcm-09-02141]\]   2014        75    M     *N. farcinica*            Kidney, liver, spleen, lung, brain                          Immunocompetent                                            Mer, Van, Cefepime, Doxycycline, Acilovir          3 days             died

  13 \[[@B37-jcm-09-02141]\]   2015        59    F     *N. cerradoensis*         Brain, skin, retroperitoneum, lung                          Post renal transplant                                      Mer, Amk                                           3 months           survived

  14 \[[@B40-jcm-09-02141]\]   2016        37    M     *N. otitidiscaviarum*     Subcutaneous soft tissue, liver, lung                       Immunocompetent                                            Cef, TMP/SMX, Mino                                 NR                 survived

  15 \[[@B38-jcm-09-02141]\]   2016        58    M     *N. nova*                 Lung, ileum                                                 B-cell Non-Hodgkin lymphoma                                TMP/SMX, Imi                                       11 months          died

  16 \[[@B39-jcm-09-02141]\]   2018        12    M     *N. elegans/aobensis/*\   Kidney, lung, brain                                         Immunocompetent                                            Pip/Taz, Amk, Imi, Cip                             6 days             died
                                                       *africana complex*                                                                                                                                                                                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** AIDS = acquired immunodeficiency syndrome; Amk = amikacin; Cef = ceftriaxone; Cip = ciprofloxacin; HIV = human immunodeficiency virus; Imi = imipenem; Line = linezolid; Mer = meropenem; Mino = minocycline; NR = not reported; Pip/Taz = piperacillin-tazobactam; RA = rheumatoid arthritis; aTNF = anti-tumor necrosis factor therapy; TMP/SMX = trimethoprim-sulfamethoxazole; Van = vancomycin; \* not further specified; \*\* Year of publication.

jcm-09-02141-t004_Table 4

###### 

*Nocardia* peritonitis in patients with continuous ambulatory peritoneal dialysis (CAPD).

  Case n°/Reference            Year \*\*   Age   Sex   Species           Cause of ESRD   Therapy Regimen                           Therapy Duration   Outcome    Catheter Removal
  ---------------------------- ----------- ----- ----- ----------------- --------------- ----------------------------------------- ------------------ ---------- ------------------
  1 \[[@B43-jcm-09-02141]\]    1981        70    M     *N. asteroides*   CIN             Ceph, Sulf                                6 weeks            survived   No
  2 \[[@B44-jcm-09-02141]\]    1990        60    M     NR                PCKD            Ofl, Tob, Ceph, Van, Azt, TMP/SMX         8 weeks            survived   No
  3 \[[@B45-jcm-09-02141]\]    1990        58    F     *N. asteroides*   NR              Ceft, Net, Van, TMP/SMX                   NR                 survived   Yes
  4 \[[@B46-jcm-09-02141]\]    1993        38    M     *N. asteroides*   SLE             Ceph, TMP/SMX                             4 weeks            died       No
  5 \[[@B47-jcm-09-02141]\]    1994        80    M     *N. nova*         NR              TMP/SMX                                   3 weeks            survived   Yes
  6 \[[@B48-jcm-09-02141]\]    2001        32    M     *N. nova*         Type 1 DM       TMP/SMX, Imi                              4 months           survived   Yes
  7 \[[@B49-jcm-09-02141]\]    2003        68    F     *N. nova*         Unknown         Cefa, Net, Ceft, Amk, Imi, TMP/SMX, Cef   2 weeks            died       No
  8 \[[@B50-jcm-09-02141]\]    2005        35    M     *N. asteroides*   CBUS            Van, Ceft, TMP/SMX, Amk, Cefu             19 weeks           survived   No
  9 \[[@B51-jcm-09-02141]\]    2008        75    M     NR                Type 2 DM       Van, TMP/SMX                              11 weeks           survived   Yes
  10 \[[@B8-jcm-09-02141]\]    2008        66    M     *N. asteroides*   Type 2 DM       Cefa, Gen TMP/SMX                         12 months          survived   Yes
  11 \[[@B52-jcm-09-02141]\]   2011        57    M     *N. asteroides*   Type 2 DM       Van, Ceft, TMP/SMX, Cef, Cip              2 weeks            died       Yes
  12 \[[@B53-jcm-09-02141]\]   2016        13    F     *N. asteroides*   DGS             Van, Cip, Ceft, Line                      8 months           survived   Yes

**Abbreviations:** Azt = aztreonam; Cef = ceftriaxone; Cefa = cefazolin; Ceft = ceftazidime; Cefu = cefuroxime; Ceph = cephalotin; Cip = ciprofloxacin; CIN = chronic interstitial nephritis; CBUS = congenital bilateral ureteral stenosis; DGS= diffuse global sclerosis; DM = diabetes mellitus; ESRD = end-stage renal disease; Gen = gentamycin; Imi = imipenem; Line = linezolid; Net = netilmycin; NR = not reported; Ofl = ofloxacin; PCKD = polycystic kidney disease; SLE = systemic lupus erythematous; Sulf = sulfisoxazole; TMP/SMX = trimethoprim-sulfamethoxazole; Tob = tobramycin; Van = vancomycin; \*\* Year of pulication.
